U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT06948747) titled 'A Study to Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy Participants' on April 28.
Brief Summary: This study will assess the effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the effect of Erythromycin on AZD5004 in healthy adult male and female participants.
Study Start Date: April 30
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Intervention:
DRUG: AZD5004
Participants will receive oral tablets of AZD5004 as single dose on the following days, (i) Day 7, Day 14, Day 21, Day 28, Day 35, D...